CLINICAL-TRIALS FOR THE TREATMENT OF SEPSIS

被引：0

作者：

THIJS, LG

机构：

来源：

ACTA ANAESTHESIOLOGICA SCANDINAVICA | 1995年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：36 / 37

页数：2

共 9 条

[1] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].

BONE, RC ;

FISHER, CJ ;

CLEMMER, TP ;

SLOTMAN, GJ ;

METZ, CA ;

BALK, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658

[2] PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL-TRIAL [J].

DHAINAUT, JFA ;

TENAILLON, A ;

LETULZO, Y ;

SCHLEMMER, B ;

SOLET, JP ;

WOLFF, M ;

HOLZAPFEL, L ;

ZENI, F ;

DREYFUSS, D ;

MIRA, JP ;

DEVATHAIRE, F ;

GUINOT, P .

CRITICAL CARE MEDICINE, 1994, 22 (11) :1720-1728

[3] ANTICYTOKINE STRATEGIES IN THE TREATMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME [J].

DINARELLO, CA ;

GELFAND, JA ;

WOLFF, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (14) :1829-1835

[4] RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

FISHER, CJ ;

DHAINAUT, JFA ;

OPAL, SM ;

PRIBBLE, JP ;

BALK, RA ;

SLOTMAN, GJ ;

IBERTI, TJ ;

RACKOW, EC ;

SHAPIRO, MJ ;

GREENMAN, RL ;

REINES, HD ;

SHELLY, MP ;

THOMPSON, BW ;

LABRECQUE, JF ;

CATALANO, MA ;

KNAUS, WA ;

SADOFF, JC ;

ASTIZ, M ;

CARPATI, C ;

BONE, RC ;

FREIDMAN, B ;

MURE, AJ ;

BRATHWAITE, C ;

SHAPIRO, E ;

MELHORN, L ;

TAYLOR, R ;

KEEGAN, M ;

OBRIEN, J ;

SCHEIN, R ;

PENA, M ;

WASSERLOUF, M ;

OROPELLO, J ;

BENJAMIN, E ;

DELGUIDICE, R ;

EMMANUEL, G ;

LIE, T ;

ANDERSON, L ;

MARSHALL, J ;

DEMAJO, W ;

ROTSTEIN, O ;

FOSTER, D ;

ABRAHAM, E ;

MIDDLETON, H ;

PERRY, C ;

LEVY, H ;

FRY, DE ;

SIMPSON, SQ ;

CROWELL, RE ;

NEIDHART, M ;

STEVENS, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1836-1843

[5] INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS [J].

FISHER, CJ ;

OPAL, SM ;

DHAINAUT, JF ;

STEPHENS, S ;

ZIMMERMAN, JL ;

NIGHTINGALE, P ;

HARRIS, SJ ;

SCHEIN, RMH ;

PANACEK, EA ;

VINCENT, JL ;

FOULKE, GE ;

WARREN, EL ;

GARRARD, C ;

PARK, G ;

BODMER, MW ;

COHEN, J ;

VANDERLINDEN, C ;

CROSS, AS ;

SADOFF, JC ;

GORECKI, J ;

DUBIN, HG ;

GARNER, C ;

KAYE, W ;

LANORE, JJ ;

MIRA, JP ;

ZIMMERMAN, J ;

DELLINGER, RP ;

TAYLOR, RW ;

DAHL, S ;

SHELLY, M ;

MORTIMER, A ;

EDWARDS, JD ;

KETT, DH ;

QUARTIN, A ;

PENA, MA ;

BAKKER, J ;

ALBERSON, TE ;

WALBY, W ;

RADCLIFFE, J ;

YOUNG, D ;

MCQUILLAM, P ;

BELLINGHAM, G ;

BURMAN, W ;

SADOFF, JS ;

YOUNG, L .

CRITICAL CARE MEDICINE, 1993, 21 (03) :318-327

[6] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].

GREENMAN, RL ;

SCHEIN, RMH ;

MARTIN, MA ;

WENZEL, RP ;

MACINTYRE, NR ;

EMMANUEL, G ;

CHMEL, H ;

KOHLER, RB ;

MCCARTHY, M ;

PLOUFFE, J ;

RUSSELL, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102

[7] INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA [J].

HOWARD, M ;

MUCHAMUEL, T ;

ANDRADE, S ;

MENON, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1205-1208

[8]

PEDUZZI P, 1987, NEW ENGL J MED, V317, P659

[9] TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA-1A HUMAN MONOCLONAL-ANTIBODY AGAINST ENDOTOXIN - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

ZIEGLER, EJ ;

FISHER, CJ ;

SPRUNG, CL ;

STRAUBE, RC ;

SADOFF, JC ;

FOULKE, GE ;

WORTEL, CH ;

FINK, MP ;

DELLINGER, RP ;

TENG, NNH ;

ALLEN, IE ;

BERGER, HJ ;

KNATTERUD, GL ;

LOBUGLIO, AF ;

SMITH, CR .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (07) :429-436

← 1 →